HIF1A and cancer: In the past two decades, advances in multi-omics technologies (genomics, transcriptomics, proteomics, and metabolomics) and experimental modelling of cancer metabolism have yielded new insights into metabolic adaptations of HIF-1-deficient cancer cells in hypoxia.